Evidence map›Paper›PMID 39260842›Full record

ArticleBMJ open2024

Screening instruments for mental disorders in primary healthcare: a scoping review protocol (SCREENING-MD).

Luis Phillipe Nagem Lopes, Danielle Maria de Souza Serio Dos Santos, Jéssica Cumpian Silva, Cristiane de Cássia Bergamaschi, Mariana Del Grossi Moura, Julia Hiromi Hori Okuyama, Luciane Cruz Lopes

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Phillipe Nagem LopesInstituto de Medicina Social, State University of Rio de Janeiro Biomedical Centre, Rio de Janeiro, Brazil.ORCID 0000-0002-9186-110X
Danielle Maria de Souza Serio Dos SantosGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil.
Jéssica Cumpian SilvaGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil.
Cristiane de Cássia BergamaschiGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil.ORCID 0000-0002-6608-1806
Mariana Del Grossi MouraGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil.
Julia Hiromi Hori OkuyamaGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil.ORCID 0000-0002-5862-7928
Luciane Cruz LopesGraduate Course in Pharmaceutical Sciences, University of Sorocaba, Sorocaba (SP), Brazil luslopesbr@gmail.com.ORCID 0000-0002-3684-3275

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWhen mental disorders go undetected until later stages, they can result in poorer health outcomes for patients. Primary healthcare (PHC) stands as a strategic setting for the early identification and management of these mental disorders, given its role as the primary care environment for health service users. This scoping review has the objective of mapping and assessing screening instruments validated for mental disorders that are applicable in PHC, particularly regarding their measurement properties. METHODS AND ANALYSIS: This scoping review will include studies that have developed and validated screening instruments for mental disorders in the PHC context, irrespective of the age group. Searches will be conducted in MEDLINE, EMBASE, LILACS, CINAHL and PsycInfo without imposing restrictions on publication status, publication year or language. Additionally, we will scrutinise the references cited in the selected studies. Our inclusion criteria encompass studies examining any measurement property recommended by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) taxonomy. The selection process, data extraction and quality assessment of studies will be performed independently by pairs of reviewers. To evaluate the risk of bias within the selected studies, we will employ the COSMIN Risk of Bias 2 tools. The collected data will undergo analysis using descriptive statistics and will be presented in an evidence gap map format for each specific mental disorder. ETHICS AND DISSEMINATION: The findings from this review will be discussed through deliberative dialogue with stakeholders and disseminated through peer-reviewed publications and conference presentations. The project was approved by the Ethics Committee for Research at the University of Sorocaba (number: 66993323.9.0000.5500). TRIAL REGISTRATION NUMBER: Open Science Framework - 10.17605/OSF.IO/Z6T5M.

Indexed as

Mass ScreeningMental DisordersPrimary Health CareHumansResearch DesignScoping Reviews as TopicMass ScreeningMENTAL HEALTHPrimary Health Care

Identifiers

PMID39260842
PMCPMC11409295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.